Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03533283. IPD Sharing: YES. Countries: 6. Publications: 1.
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
ClinicalTrials.gov study NCT04231877. IPD Sharing: NO. Countries: 1. Publications: 2.
Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation
ClinicalTrials.gov study NCT01516567. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma
ClinicalTrials.gov study NCT06777290. IPD Sharing: NO. Countries: 1. Publications: 1.
Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT02728882. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
ClinicalTrials.gov study NCT04133636. IPD Sharing: YES. Countries: 8. Publications: 1.
90Y-ibritumomab Tiuxetan Consolidation After 6th R-CHOP Chemotherapy in Patients With Bulky Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT01157988. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma
ClinicalTrials.gov study NCT01567709. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination
ClinicalTrials.gov study NCT01618136. IPD Sharing: Not stated. Countries: 1. Publications: 1.
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
ClinicalTrials.gov study NCT06137118. IPD Sharing: YES. Countries: 13. Publications: 0.
Identification of Donor Specific B Cells and Antibody Mediated Rejection
ClinicalTrials.gov study NCT02133248. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Dual Target CAR-T Cells in B-cell Lymphoma
ClinicalTrials.gov study NCT04723914. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
ClinicalTrials.gov study NCT05463263. IPD Sharing: NO. Countries: 3. Publications: 1.
Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma
ClinicalTrials.gov study NCT00169468. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02660710. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT00140660. IPD Sharing: NO. Countries: 3. Publications: 5.
A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib
ClinicalTrials.gov study NCT01324596. IPD Sharing: YES. Countries: 2. Publications: 2.
External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00271050. IPD Sharing: Not stated. Countries: 1. Publications: 26.
Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT01974479. IPD Sharing: Not stated. Countries: 1. Publications: 5.
A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell Lymphoma
ClinicalTrials.gov study NCT05200312. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.